查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1833577

2032 年按鈕式安全採血針市場預測：按規格尺寸、穿透深度、通路、應用、最終用戶和地區進行的全球分析

Button-activated Safety Lancet Market Forecasts to 2032 - Global Analysis By Gauge Size (18G-21G (High Flow), 22G-25G (Moderate Flow), and 26G-30G (Low Flow)), Penetration Depth, Distribution Channel, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，全球按鈕式安全採血針市場預計在 2025 年達到 7.7338 億美元，到 2032 年將達到 19.2335 億美元，預測期內的複合年成長率為 13.9%。

按鈕式安全採血針是用於毛細血管採血的無菌設備，常用於血糖監測和診斷測試。它們在外殼內安裝了一個隱藏式針頭，只需按一下按鈕即可釋放。這種設計可以實現可控的快速穿刺，最大限度地減少不適感，同時防止針頭意外暴露。使用後針頭會自動縮回，確保採血過程中醫護人員和病患的安全、感染控制和一次性使用的可靠性。

根據國際糖尿病聯盟發布的數據，預計到2050年，非洲糖尿病患者數量將達到6,000萬，與2024年該地區糖尿病盛行率相比成長約142%。

慢性病增多

糖尿病、心血管疾病和腎臟損害等慢性疾病負擔日益加重，推動了對可靠血液採集設備（如按鈕啟動的安全採血針）的需求。這些設備提供了一種更安全、更有效的毛細血管採血方法，尤其適用於長期疾病監測。隨著醫療保健系統向預防保健和早期診斷轉變，採血針正成為常規檢測通訊協定的重要組成部分。針頭設計和減輕疼痛機制的技術進步正在提高患者的依從性。人口老化和新興國家診斷意識的不斷增強進一步擴大了用戶群。個人化醫療和照護現場的興起也在推動市場發展。

替代性非侵入性檢測技術的興起

穿戴式生物感測器和光學血糖監測儀等非侵入式診斷工具的出現，正在挑戰傳統的採血針針檢測方法。這些替代技術提供無痛監測和持續數據追蹤，吸引了精通技術、不願使用針頭的患者。經皮和唾液檢測的創新正在獲得發展動力，尤其是在居家照護和小兒科領域。隨著數位健康平台整合這些技術，某些細分市場對採血針的依賴程度可能會降低。監管部門對非侵入式設備的支援正在加速其市場准入和普及。這種轉變可能會限制按鈕式安全採血針在先進醫療生態系統中的擴張。

與數位健康和​​遠端醫療的整合

遠端醫療和遠端患者監護的興起為按鈕式安全採血針創造了新的機會。這些設備擴大與家庭診斷套件和連線健診平台捆綁銷售，以支援分散式護理。與行動應用程式和雲端基礎數據系統的整合，可以無縫追蹤檢測結果和患者依從性。新興趨勢包括藍牙連接的智慧採血針和用於慢性病管理的自動記錄功能。醫療保健提供者正在利用這些工具來增強虛擬會診並減少就診次數。隨著數位生態系統的發展，安全採血針正成為遠距離診斷工作流程的重要一環。

仿冒品品

不合格產品通常未經適當消毒，且不符合國際安全標準，導致感染風險增加和結果不準確。線上市場和分散的通路助長了假冒設備的氾濫。監管機構已加強監管和執法力度以遏制這一問題，但新興市場仍有監管缺口。製造商正在投資防篡改包裝和可追溯性技術，以保護產品的完整性。如果沒有嚴格的品管，消費者信任和臨床可靠性將面臨風險。

COVID-19的影響：

新冠疫情加速了對安全易用的採血設備的需求，尤其是在居家醫療和隔離環境。按鈕式安全採血針在隔離期間的大規模檢測和慢性病監測中發揮了關鍵作用。雖然供應鏈中斷最初阻礙了生產，但製造商透過自動化和本地籌資策略進行了調整。監管機構加快了家用設備的核准，擴大了市場進入。疫情過後，對感染控制和分散式照護的重視程度不斷提高，使得採血針在醫療機構中繼續廣泛應用。

零售藥局預計將成為預測期內最大的市場

由於零售藥局的便利性和高客流量，預計在預測期內將佔據最大的市場佔有率。藥局是自檢檢測套組和慢性病監測工具的主要分銷點。採血採血針製造商和連鎖藥局之間的策略聯盟正在提高產品的知名度和可得性。藥局營運的技術升級，例如數位庫存和電子處方箋系統，正在簡化採血針的銷售。非處方診斷和健康計劃的興起進一步推動了需求。隨著消費者健康意識的不斷增強，零售藥局仍然是採血針分銷和教育的中心。

預計預測期內居家醫療領域將以最高的複合年成長率成長。

在以患者為中心的醫療服務轉變的推動下，預計居家照護領域將在預測期內實現最高成長率。遠端監控和自我檢測的興起使人們能夠在家中管理慢性疾病。易於使用且能最大程度減輕疼痛的採血針在老年和兒科患者中越來越受歡迎。與遠端醫療平台和行動醫療應用程式的整合正在提高家用採血針的效用。製造商正專注於人體工學設計和套件，以滿足這一細分市場的需求。隨著醫療保健的去中心化，家庭護理已成為安全採血針的關鍵成長領域。

比最大的地區

預計亞太地區將在預測期內佔據最大的市場佔有率，這得益於醫療基礎設施的不斷擴張和診斷需求的不斷成長。中國、印度和日本等國家正在投資公共衛生計畫和慢性病篩檢舉措。本地製造和優惠的政府政策正在推動採血針的產量和價格承受能力。該地區正在見證數位醫療工具和行動診斷工具的快速普及，從而推動採血針的普及。跨國公司與本地經銷商之間的策略合作夥伴關係正在加速市場進入。亞太地區糖尿病人口眾多且認知度不斷提高，仍是市場規模的主要驅動力。

複合年成長率最高的地區：

在技​​術創新和強勁的醫療保健支出的推動下，北美地區預計將在預測期內呈現最高的複合年成長率。美國和加拿大在智慧採血針和整合診斷平台的開發方面處於領先地位。監管機構正在簡化家用和連網型設備設備的核准途徑，以促進更快的商業化。遠端醫療和遠端監控的廣泛應用推動了對易於使用的採血針的需求。該地區也受益於強大的報銷框架和消費者意識宣傳活動。隨著精準診斷的發展，北美將繼續為採血針的創新和成長樹立標竿。

免費客製化服務：

此報告的訂閱者可以選擇以下免費自訂選項之一：

  • 公司簡介
    • 對最多三家其他市場公司進行全面分析
    • 主要企業的SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶興趣對主要國家進行的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 主要研究資料
    • 次級研究資訊來源
    • 先決條件

第3章市場走勢分析

  • 驅動程式
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • COVID-19的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球按鈕式安全採血針市場（依規格尺寸）

  • 18G至21G（高流量）
  • 22G至25G（中等流量）
  • 26G至30G（低流量）

6. 全球按鈕啟動安全採血針市場（按穿透深度）

  • 小於1.0毫米
  • 1.0～2.0mm

7. 全球按鈕啟動安全採血針市場（按通路）

  • 直銷
  • 零售藥局
  • 醫療用品經銷商
  • 線上平台

8. 全球按鈕啟動安全採血針市場（按應用）

  • 血糖值檢測
  • 新生兒足跟穿刺
  • 血紅素檢測
  • 膽固醇檢測
  • 血液凝固檢驗
  • 其他用途

9. 全球按鈕啟動安全採血針市場（按最終用戶）

  • 醫院
  • 血庫
  • 診斷實驗室
  • 居家照護環境
  • 其他最終用戶

第10章。全球按鈕啟動安全採血針市場（按地區）

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第11章 重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司概況

  • Cardinal Health
  • Improve Medical
  • HTL-STREFA
  • Arkray Inc.
  • SARSTEDT AG & Co. KG
  • Lifescan Inc.
  • Terumo Corporation
  • Smiths Medical
  • Greiner Bio-One
  • Nipro Corporation
  • Medline Industries
  • Roche Diagnostics
  • Owen Mumford
  • Abbott Laboratories
  • Braun Melsungen AG
Product Code: SMRC31410

According to Stratistics MRC, the Global Button-activated Safety Lancet Market is accounted for $773.38 million in 2025 and is expected to reach $1923.35 million by 2032 growing at a CAGR of 13.9% during the forecast period. A button-activated safety lancet is a sterile device used for obtaining capillary blood, often in glucose monitoring and diagnostic tests. It incorporates a hidden needle secured inside a casing, released by a simple button press. This design provides controlled, rapid puncturing with minimal discomfort while preventing accidental needle exposure. The needle retracts automatically after use, ensuring safety, infection control, and single-use reliability for both medical staff and patients during blood sampling procedures.

According to data published by the International Diabetes Federation, the prevalence of diabetes is estimated to reach 60 million in Africa by 2050. This increase is around 142% as compared to the diabetes prevalence in the region in 2024.

Market Dynamics:

Driver:

Rising prevalence of chronic diseases

The growing burden of chronic illnesses such as diabetes, cardiovascular conditions, and renal disorders is fueling demand for reliable blood sampling tools like button-activated safety lancets. These devices offer a safer and more efficient method for capillary blood collection, especially in long-term disease monitoring. As healthcare systems shift toward preventive care and early diagnosis, lancets are becoming integral to routine testing protocols. Technological advancements in needle design and pain-reduction mechanisms are improving patient compliance. Aging populations and increasing diagnostic awareness in emerging economies are further expanding the user base. The market is also benefiting from the rise of personalized medicine and point-of-care diagnostics.

Restraint:

Rise of alternative non-invasive testing technologies

The emergence of non-invasive diagnostic tools such as wearable biosensors and optical glucose monitors is challenging the growth of traditional lancet-based testing. These alternatives offer pain-free monitoring and continuous data tracking, appealing to tech-savvy and needle-averse patients. Innovations in transdermal and saliva-based testing are gaining traction, especially in homecare and pediatric settings. As digital health platforms integrate these technologies, the reliance on lancets may decline in certain segments. Regulatory support for non-invasive devices is accelerating their market entry and adoption. This shift could limit the expansion of button-activated safety lancets in advanced healthcare ecosystems.

Opportunity:

Integration with digital health and telemedicine

The growing adoption of telehealth and remote patient monitoring is creating new opportunities for button-activated safety lancets. These devices are increasingly bundled with home diagnostic kits and connected health platforms to support decentralized care. Integration with mobile apps and cloud-based data systems enables seamless tracking of test results and patient adherence. Emerging trends include smart lancets with Bluetooth connectivity and auto-logging features for chronic disease management. Healthcare providers are leveraging these tools to enhance virtual consultations and reduce hospital visits. As digital ecosystems evolve, safety lancets are becoming essential components of remote diagnostic workflows.

Threat:

Counterfeit products and substandard quality

Substandard products often lack proper sterilization and fail to meet international safety standards, leading to increased risk of infection and inaccurate results. Online marketplaces and fragmented distribution channels are contributing to the spread of unauthorized devices. Regulatory bodies are ramping up surveillance and enforcement to curb this issue, but gaps remain in emerging markets. Manufacturers are investing in tamper-proof packaging and traceability technologies to protect product integrity. Without stringent quality control, the market risks erosion of consumer trust and clinical reliability.

Covid-19 Impact:

The COVID-19 pandemic accelerated the demand for safe and easy-to-use blood sampling tools, especially in homecare and quarantine settings. Button-activated safety lancets played a crucial role in mass testing and monitoring of chronic conditions during lockdowns. Supply chain disruptions initially hampered production, but manufacturers adapted through automation and regional sourcing strategies. Regulatory agencies fast-tracked approvals for home-use devices, expanding market access. Post-pandemic, the emphasis on infection control and decentralized care continues to drive lancet adoption across healthcare settings.

The retail pharmacies segment is expected to be the largest during the forecast period

The retail pharmacies segment is expected to account for the largest market share during the forecast period, due to its accessibility and high consumer footfall. Pharmacies serve as key distribution points for self-testing kits and chronic disease monitoring tools. Strategic collaborations between lancet manufacturers and pharmacy chains are enhancing product visibility and availability. Technological upgrades in pharmacy operations, including digital inventory and e-prescription systems, are streamlining lancet sales. The rise of over-the-counter diagnostics and wellness programs is further boosting demand. As consumer health awareness grows, retail pharmacies remain central to lancet distribution and education.

The homecare settings segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the homecare settings segment is predicted to witness the highest growth rate, driven by the shift toward patient-centric care. The rise of remote monitoring and self-testing is empowering individuals to manage chronic conditions from home. Lancets designed for ease of use and minimal pain are gaining popularity among elderly and pediatric users. Integration with telemedicine platforms and mobile health apps is enhancing the utility of home-use lancets. Manufacturers are focusing on ergonomic designs and bundled kits to cater to this segment. As healthcare decentralizes, homecare emerges as a vital growth frontier for safety lancets.

Region with largest share:

During the forecast period, the Asia Pacificregion is expected to hold the largest market share, supported by expanding healthcare infrastructure and rising diagnostic demand. Countries like China, India, and Japan are investing in public health programs and chronic disease screening initiatives. Local manufacturing and favorable government policies are boosting lancet production and affordability. The region is witnessing rapid adoption of digital health tools and mobile diagnostics, enhancing lancet penetration. Strategic alliances between global players and regional distributors are accelerating market access. With a large diabetic population and growing awareness, Asia Pacific remains a key driver of market volume.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, fuelled by technological innovation and robust healthcare spending. The U.S. and Canada are leading in the development of smart lancets and integrated diagnostic platforms. Regulatory agencies are streamlining approval pathways for home-use and connected devices, encouraging rapid commercialization. High adoption of telehealth and remote monitoring is boosting demand for user-friendly lancets. The region also benefits from strong reimbursement frameworks and consumer awareness campaigns. As precision diagnostics evolve, North America continues to set the benchmark for lancet innovation and growth.

Key players in the market

Some of the key players in Button-activated Safety Lancet Market include Cardinal Health, Improve Medical, HTL-STREFA, Arkray Inc., SARSTEDT AG & Co. KG, Lifescan Inc., Terumo Corporation, Smiths Medical, Greiner Bio-One, Nipro Corporation, Medline Industries, Roche Diagnostics, Owen Mumford, Abbott Laboratories, and Braun Melsungen AG.

Key Developments:

In July2025, Cardinal Health announced the expansion of Equity Rx, to help meet the needs of people across Ohio and beyond who cannot afford their prescription medications. Launched as a pilot in Ohio in 2023, Equity Rx was created through a partnership of the Cardinal Health Foundation, the Charitable Healthcare Network (CHN) and St. Vincent de Paul Charitable Pharmacy in Cincinnati, Ohio.

In September2021, LifeScanand Welldoc, a digital health leader revolutionizing chronic care, announced a strategic partnership to incorporate Welldoc's chronic condition platform, supporting hypertension, heart failure, diabetes, pre-diabetes and behavioral health, into the new OneTouch(R) Solutions portal, designed to offer a choice of support, guidance and digital tools to help people not just manage diabetes but thrive.

Gauge Sizes Covered:

  • 18G-21G (High Flow)
  • 22G-25G (Moderate Flow)
  • 26G-30G (Low Flow)

Penetration Depths Covered:

  • <1.0 mm
  • 1.0-2.0 mm

Distribution Channels Covered:

  • Direct Sales
  • Retail Pharmacies
  • Medical Supply Distributors
  • Online Platforms

Applications Covered:

  • Blood Glucose Testing
  • Neonatal Heel Stick
  • Hemoglobin Testing
  • Cholesterol Testing
  • Coagulation Testing
  • Other Applications

End Users Covered:

  • Hospitals
  • Blood Banks
  • Diagnostic Laboratories
  • Homecare Settings
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Button-activated Safety Lancet Market, By Gauge Size

  • 5.1 Introduction
  • 5.2 18G-21G (High Flow)
  • 5.3 22G-25G (Moderate Flow)
  • 5.4 26G-30G (Low Flow)

6 Global Button-activated Safety Lancet Market, By Penetration Depth

  • 6.1 Introduction
  • 6.2 <1.0 mm
  • 6.3 1.0-2.0 mm

7 Global Button-activated Safety Lancet Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Direct Sales
  • 7.3 Retail Pharmacies
  • 7.4 Medical Supply Distributors
  • 7.5 Online Platforms

8 Global Button-activated Safety Lancet Market, By Application

  • 8.1 Introduction
  • 8.2 Blood Glucose Testing
  • 8.3 Neonatal Heel Stick
  • 8.4 Hemoglobin Testing
  • 8.5 Cholesterol Testing
  • 8.6 Coagulation Testing
  • 8.7 Other Applications

9 Global Button-activated Safety Lancet Market, By End User

  • 9.1 Introduction
  • 9.2 Hospitals
  • 9.3 Blood Banks
  • 9.4 Diagnostic Laboratories
  • 9.5 Homecare Settings
  • 9.6 Other End Users

10 Global Button-activated Safety Lancet Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Cardinal Health
  • 12.2 Improve Medical
  • 12.3 HTL-STREFA
  • 12.4 Arkray Inc.
  • 12.5 SARSTEDT AG & Co. KG
  • 12.6 Lifescan Inc.
  • 12.7 Terumo Corporation
  • 12.8 Smiths Medical
  • 12.9 Greiner Bio-One
  • 12.10 Nipro Corporation
  • 12.11 Medline Industries
  • 12.12 Roche Diagnostics
  • 12.13 Owen Mumford
  • 12.14 Abbott Laboratories
  • 12.15 Braun Melsungen AG

List of Tables

  • Table 1 Global Button-activated Safety Lancet Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Button-activated Safety Lancet Market Outlook, By Gauge Size (2024-2032) ($MN)
  • Table 3 Global Button-activated Safety Lancet Market Outlook, By 18G-21G (High Flow) (2024-2032) ($MN)
  • Table 4 Global Button-activated Safety Lancet Market Outlook, By 22G-25G (Moderate Flow) (2024-2032) ($MN)
  • Table 5 Global Button-activated Safety Lancet Market Outlook, By 26G-30G (Low Flow) (2024-2032) ($MN)
  • Table 6 Global Button-activated Safety Lancet Market Outlook, By Penetration Depth (2024-2032) ($MN)
  • Table 7 Global Button-activated Safety Lancet Market Outlook, By <1.0 mm (2024-2032) ($MN)
  • Table 8 Global Button-activated Safety Lancet Market Outlook, By 1.0-2.0 mm (2024-2032) ($MN)
  • Table 9 Global Button-activated Safety Lancet Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 10 Global Button-activated Safety Lancet Market Outlook, By Direct Sales (2024-2032) ($MN)
  • Table 11 Global Button-activated Safety Lancet Market Outlook, By Retail Pharmacies (2024-2032) ($MN)
  • Table 12 Global Button-activated Safety Lancet Market Outlook, By Medical Supply Distributors (2024-2032) ($MN)
  • Table 13 Global Button-activated Safety Lancet Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 14 Global Button-activated Safety Lancet Market Outlook, By Application (2024-2032) ($MN)
  • Table 15 Global Button-activated Safety Lancet Market Outlook, By Blood Glucose Testing (2024-2032) ($MN)
  • Table 16 Global Button-activated Safety Lancet Market Outlook, By Neonatal Heel Stick (2024-2032) ($MN)
  • Table 17 Global Button-activated Safety Lancet Market Outlook, By Hemoglobin Testing (2024-2032) ($MN)
  • Table 18 Global Button-activated Safety Lancet Market Outlook, By Cholesterol Testing (2024-2032) ($MN)
  • Table 19 Global Button-activated Safety Lancet Market Outlook, By Coagulation Testing (2024-2032) ($MN)
  • Table 20 Global Button-activated Safety Lancet Market Outlook, By Other Applications (2024-2032) ($MN)
  • Table 21 Global Button-activated Safety Lancet Market Outlook, By End User (2024-2032) ($MN)
  • Table 22 Global Button-activated Safety Lancet Market Outlook, By Hospitals (2024-2032) ($MN)
  • Table 23 Global Button-activated Safety Lancet Market Outlook, By Blood Banks (2024-2032) ($MN)
  • Table 24 Global Button-activated Safety Lancet Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
  • Table 25 Global Button-activated Safety Lancet Market Outlook, By Homecare Settings (2024-2032) ($MN)
  • Table 26 Global Button-activated Safety Lancet Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.